State of Wisconsin Investment Board’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

State of Wisconsin Investment Board’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-54,575	Closed	-$364K	–	2622
2023 Q3	$364K	Sell	54,575 -1,287	-2%	-$10.7K	﹤0.01%	1961
2023 Q2	$506K	Sell	55,862 -2,981	-5%	-$26.3K	﹤0.01%	1823
2023 Q1	$428K	Sell	58,843 -6,543	-10%	-$48.5K	﹤0.01%	1935
2022 Q4	$477K	Buy	65,386 +18,877	+41%	+$140K	﹤0.01%	1916
2022 Q3	$360K	Buy	46,509 +6,826	+17%	+$57.9K	﹤0.01%	2133
2022 Q2	$270K	Buy	39,683 +9,783	+33%	+$74.9K	﹤0.01%	2371
2022 Q1	$238K	Buy	+29,900	New	+$190K	﹤0.01%	2143

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

State of Wisconsin Investment Board's PNT Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 54,575 shares — an estimated $364K sold.

State of Wisconsin Investment Board first reported a position in PNT in Q1 2022 and held it in 7 quarters. The position peaked at $506K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

State of Wisconsin Investment Board reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 54,575 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $364K.
State of Wisconsin Investment Board first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 7 quarters.
State of Wisconsin Investment Board's POINT Biopharma Global Inc. Common Stock position peaked at $506K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.